688278 特宝生物
已收盘 03-02 15:00:00
资讯
新帖
简况
每周股票复盘：特宝生物（688278）2025年净利增25.39%
证券之星 · 02-15
每周股票复盘：特宝生物（688278）2025年净利增25.39%
特宝生物：2025年业绩稳健增长 “益佩生”打造第二增长曲线
中金财经 · 02-11
特宝生物：2025年业绩稳健增长 “益佩生”打造第二增长曲线
2月11日特宝生物涨6.01%，东方红睿丰LOF基金重仓该股
证券之星 · 02-11
2月11日特宝生物涨6.01%，东方红睿丰LOF基金重仓该股
特宝生物2025年初步净利润同比增长25.4%
投资观察 · 02-10
特宝生物2025年初步净利润同比增长25.4%
特宝生物发布2025年度业绩快报，盈利10.377亿元
证券之星 · 02-10
特宝生物发布2025年度业绩快报，盈利10.377亿元
国金证券：给予特宝生物买入评级，目标价92.74元
证券之星 · 02-10
国金证券：给予特宝生物买入评级，目标价92.74元
特宝生物（688278）披露向不特定对象发行可转换公司债券相关议案，2月3日股价上涨0.53%
证券之星 · 02-03
特宝生物（688278）披露向不特定对象发行可转换公司债券相关议案，2月3日股价上涨0.53%
特宝生物（688278）披露获得第九批国家级制造业单项冠军企业认定，1月29日股价下跌0.54%
证券之星 · 01-29
特宝生物（688278）披露获得第九批国家级制造业单项冠军企业认定，1月29日股价下跌0.54%
1月27日特宝生物发生1笔大宗交易 成交金额836万元
证券之星 · 01-27
1月27日特宝生物发生1笔大宗交易 成交金额836万元
特宝生物(688278.SH)拟发行可转债募资不超15.33亿元
智通财经 · 01-26
特宝生物(688278.SH)拟发行可转债募资不超15.33亿元
每周股票复盘：特宝生物（688278）两日现大宗交易超1454万元
证券之星 · 01-25
每周股票复盘：特宝生物（688278）两日现大宗交易超1454万元
1月23日特宝生物现758.8万元大宗交易
证券之星 · 01-23
1月23日特宝生物现758.8万元大宗交易
1月22日特宝生物发生1笔大宗交易 成交金额695.33万元
证券之星 · 01-22
1月22日特宝生物发生1笔大宗交易 成交金额695.33万元
每周股票复盘：特宝生物（688278）实控人续签一致行动协议
证券之星 · 01-18
每周股票复盘：特宝生物（688278）实控人续签一致行动协议
1月13日特宝生物发生1笔大宗交易 成交金额758.14万元
证券之星 · 01-13
1月13日特宝生物发生1笔大宗交易 成交金额758.14万元
每周股票复盘：特宝生物（688278）发生大宗交易成交1799.8万元
证券之星 · 01-11
每周股票复盘：特宝生物（688278）发生大宗交易成交1799.8万元
1月8日特宝生物发生1笔大宗交易 成交金额1799.8万元
证券之星 · 01-08
1月8日特宝生物发生1笔大宗交易 成交金额1799.8万元
每周股票复盘：特宝生物（688278）募集资金专户已全部注销
证券之星 · 01-02
每周股票复盘：特宝生物（688278）募集资金专户已全部注销
特宝生物（688278）披露关于募集资金专户完成销户的公告，12月29日股价上涨0.45%
证券之星 · 2025-12-29
特宝生物（688278）披露关于募集资金专户完成销户的公告，12月29日股价上涨0.45%
特宝生物（688278）披露首次公开发行股票募投项目结项公告，12月22日股价下跌0.66%
证券之星 · 2025-12-22
特宝生物（688278）披露首次公开发行股票募投项目结项公告，12月22日股价下跌0.66%
加载更多
公司概况
公司名称：
厦门特宝生物工程股份有限公司
所属行业：
医药制造业
上市日期：
2020-01-17
主营业务：
厦门特宝生物工程股份有限公司的主营业务是重组蛋白质及其长效修饰药物研发、生产和销售。公司的主要产品是派格宾、益佩生、珮金、特尔立、特尔津、特尔康、愈适达。公司产品荣膺国家重大新药创制科技重大专项成果，成功入选“2023年度中国医药生物技术十大进展”，获评“2024年度药物创新成就奖”。
发行价格：
8.24
{"stockData":{"symbol":"688278","market":"SH","secType":"STK","nameCN":"特宝生物","latestPrice":73.77,"timestamp":1772434800000,"preClose":75.13,"halted":0,"volume":2647508,"delay":0,"changeRate":-0.0181,"floatShares":408000000,"shares":408000000,"eps":2.3019,"marketStatus":"已收盘","change":-1.36,"latestTime":"03-02 15:00:00","open":74.82,"high":74.85,"low":72.45,"amount":195000000,"amplitude":0.0319,"askPrice":73.77,"askSize":1,"bidPrice":73.75,"bidSize":70,"shortable":0,"etf":0,"ttmEps":2.3019,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772501400000},"marketStatusCode":5,"adr":0,"adjPreClose":75.13,"symbolType":"stock_kcb","openAndCloseTimeList":[[1772415000000,1772422200000],[1772427600000,1772434800000]],"highLimit":82.64,"lowLimit":67.62,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":408189480,"isCdr":false,"pbRate":10.01,"roa":"--","peRate":32.047439,"roe":"23.82%","epsLYR":2.03,"committee":0.743842,"marketValue":30112000000,"turnoverRate":0.0065,"status":1,"afterMarket":{"amount":0,"volume":0,"close":73.77,"buyVolume":0,"sellVolume":0,"time":1772436837558,"indexStatus":"已收盘 03-02 15:30:00","preClose":75.13},"floatMarketCap":30112000000},"requestUrl":"/m/hq/s/688278","defaultTab":"news","newsList":[{"id":"2611536145","title":"每周股票复盘：特宝生物（688278）2025年净利增25.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611536145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611536145?lang=zh_cn&edition=full","pubTime":"2026-02-15 02:04","pubTimestamp":1771092256,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘，特宝生物报收于72.39元，较上周的69.11元上涨4.75%。本周，特宝生物2月11日盘中最高价报74.2元。2月9日盘中最低价报68.41元。特宝生物当前最新总市值295.49亿元，在生物制品板块市值排名10/51，在两市A股市值排名735/5189。业绩披露要点业绩快报特宝生物近日即将发布2025年年报，根据2月10日发布的业绩快报，归属净利润盈利10.377亿元，同比增长25.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2610847934","title":"特宝生物：2025年业绩稳健增长 “益佩生”打造第二增长曲线","url":"https://stock-news.laohu8.com/highlight/detail?id=2610847934","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610847934?lang=zh_cn&edition=full","pubTime":"2026-02-11 19:50","pubTimestamp":1770810602,"startTime":"0","endTime":"0","summary":"近日，厦门特宝生物工程股份有限公司发布2025年度业绩快报。全新增长引擎：长效生长激素“益佩生”上市即放量2025年该公司业绩的新亮点来自新产品“益佩生”。国金证券将“益佩生”视为该公司的“第二增长曲线”。国金证券认为，尽管2025年第三季度因益佩生上市推广导致销售费用短期上升，利润增速承压，但随着该产品正式纳入医保并加速进院，以及派格宾治愈适应症的市场教育深化，特宝生物2026年业绩增长有望换挡提速。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260211/32012948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2610984008","title":"2月11日特宝生物涨6.01%，东方红睿丰LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610984008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610984008?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:31","pubTimestamp":1770798709,"startTime":"0","endTime":"0","summary":"证券之星消息，2月11日特宝生物涨6.01%，收盘报73.0元，换手率1.24%，成交量5.05万手，成交额3.67亿元。重仓特宝生物的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共25家，其中持有数量最多的公募基金为东方红资产管理的东方红睿丰LOF。东方红睿丰LOF目前规模为21.43亿元，最新净值2.155，较上一交易日下跌0.14%，近一年上涨61.54%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100025703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"1175116033","title":"特宝生物2025年初步净利润同比增长25.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1175116033","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175116033?lang=zh_cn&edition=full","pubTime":"2026-02-10 20:13","pubTimestamp":1770725635,"startTime":"0","endTime":"0","summary":"厦门特宝生物股份有限公司（股票代码：688278）近日公布的初步财务数据显示，公司2025年净利润预计实现同比增长25.4%。这一业绩表现凸显了公司在生物科技领域的稳健增长势头。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2610532644","title":"特宝生物发布2025年度业绩快报，盈利10.377亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610532644","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610532644?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:40","pubTimestamp":1770723632,"startTime":"0","endTime":"0","summary":"证券之星消息，特宝生物近日即将发布2025年年报，根据2月10日发布的业绩快报，归属净利润盈利10.377亿元，同比增长25.39%。实现营业总收入 369,556.72 万元，同比增长 31.18%；实现归属于母公司所有者的净利润 103,773.40 万元，同比增长 25.39%；实现归属于母公司所有者的扣除非经常性损益的净利润 106,749.22万元，同比增长 29.09%。报告期末公司总资产为 436,855.25 万元，较报告期期初增长 43.21%；归属于母公司的所有者权益 345,607.64 万元，较报告期初增长 35.36%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000034193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2610926316","title":"国金证券：给予特宝生物买入评级，目标价92.74元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610926316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610926316?lang=zh_cn&edition=full","pubTime":"2026-02-10 12:14","pubTimestamp":1770696895,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,马居东近期对特宝生物进行研究并发布了研究报告《PEG长效药物领军企业，益佩生打造第二增长曲线》，给予特宝生物买入评级，目标价92.74元。派格宾收入从2016年0.7亿快速增长至2024年的24.5亿，并仍呈持续放量增长。给予公司26年27倍PE估值，目标市值379亿元，目标价92.74元，给予“买入”评级。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000017365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278"],"gpt_icon":0},{"id":"2608870360","title":"特宝生物（688278）披露向不特定对象发行可转换公司债券相关议案，2月3日股价上涨0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608870360","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608870360?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:48","pubTimestamp":1770130099,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，特宝生物报收于74.6元，较前一交易日上涨0.53%，最新总市值为304.51亿元。该股当日开盘74.47元，最高75.55元，最低73.77元，成交额达1亿元，换手率为0.33%。本次发行募集资金总额不超过153,326.69万元，用于新药研发、生物技术创新融合中心建设及创新药物生产改扩项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2607806036","title":"特宝生物（688278）披露获得第九批国家级制造业单项冠军企业认定，1月29日股价下跌0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607806036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607806036?lang=zh_cn&edition=full","pubTime":"2026-01-29 22:47","pubTimestamp":1769698031,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，特宝生物报收于75.99元，较前一交易日下跌0.54%，最新总市值为310.18亿元。该股当日开盘76.01元，最高76.99元，最低75.73元，成交额达1.15亿元，换手率为0.37%。近日，厦门特宝生物工程股份有限公司发布公告称，公司于近日获得工业和信息化部颁发的《制造业单项冠军企业证书》，被认定为第九批制造业单项冠军企业，凭借聚乙二醇干扰素α-2b注射液的产品技术优势和市场地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900043917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2606207696","title":"1月27日特宝生物发生1笔大宗交易 成交金额836万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606207696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606207696?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:37","pubTimestamp":1769506622,"startTime":"0","endTime":"0","summary":"证券之星消息，1月27日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格76元，成交11万股，成交金额836万元，买方营业部为中信证券股份有限公司总部，卖方营业部为广发证券股份有限公司广州花城大道证券营业部。近三个月该股共发生8笔大宗交易，合计成交7097.0手。该股近期无解禁股上市。截至2026年1月27日收盘，特宝生物报收于76.0元，上涨1.36%，换手率0.54%，成交量2.2万手，成交额1.68亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700029973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2606263243","title":"特宝生物(688278.SH)拟发行可转债募资不超15.33亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606263243","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606263243?lang=zh_cn&edition=full","pubTime":"2026-01-26 21:35","pubTimestamp":1769434512,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特宝生物(688278.SH)发布公告，公司拟向不特定对象发行可转债，募集资金总额(含发行费用)不超过15.33亿元(含本数)，扣除发行费用后的募集资金净额将用于：新药研发项目、生物技术创新融合中心建设项目、特宝生物创新药物生产改扩项目-产线建设。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2606623247","title":"每周股票复盘：特宝生物（688278）两日现大宗交易超1454万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606623247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606623247?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:55","pubTimestamp":1769280910,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，特宝生物报收于75.88元，较上周的75.9元下跌0.03%。本周，特宝生物1月21日盘中最高价报79.8元。1月20日盘中最低价报74.72元。特宝生物当前最新总市值309.73亿元，在生物制品板块市值排名10/51，在两市A股市值排名710/5182。本周关注点来自交易信息汇总：1月22日至23日，特宝生物连续两日发生大宗交易，合计成交额达1454.13万元。1月22日，特宝生物发生1笔大宗交易，成交金额为695.33万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2605475730","title":"1月23日特宝生物现758.8万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2605475730","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605475730?lang=zh_cn&edition=full","pubTime":"2026-01-23 17:49","pubTimestamp":1769161760,"startTime":"0","endTime":"0","summary":"证券之星消息，1月23日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格75.88元，成交10万股，成交金额758.8万元，买方营业部为中信证券股份有限公司总部，卖方营业部为广发证券股份有限公司郑州航海东路证券营业部。近三个月该股共发生7笔大宗交易，合计成交5997.0手。该股近期无解禁股上市。截至2026年1月23日收盘，特宝生物报收于75.88元，下跌0.69%，换手率0.55%，成交量2.25万手，成交额1.71亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300029907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2605464630","title":"1月22日特宝生物发生1笔大宗交易 成交金额695.33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605464630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605464630?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:43","pubTimestamp":1769075035,"startTime":"0","endTime":"0","summary":"证券之星消息，1月22日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格76.41元，成交9.1万股，成交金额695.33万元，买方营业部为国泰海通证券股份有限公司总部，卖方营业部为国泰海通证券股份有限公司总部。近三个月该股共发生6笔大宗交易，合计成交4997.0手。截至2026年1月22日收盘，特宝生物报收于76.41元，下跌2.2%，换手率0.52%，成交量2.13万手，成交额1.63亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200029380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2604925349","title":"每周股票复盘：特宝生物（688278）实控人续签一致行动协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925349","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925349?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:39","pubTimestamp":1768678748,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，特宝生物报收于75.9元，较上周的80.59元下跌5.82%。本周，特宝生物1月12日盘中最高价报81.13元。1月15日盘中最低价报74.3元。特宝生物当前最新总市值309.82亿元，在生物制品板块市值排名10/51，在两市A股市值排名676/5183。双方在公司重要事项决策上保持一致行动，表决意见不一致时以杨英女士意见为准。协议不可单方解除，承诺在有效期内不主动辞去董事或高管职务。截至公告日，杨英持有公司33.83%股份，孙黎持有7.98%股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2603450201","title":"1月13日特宝生物发生1笔大宗交易 成交金额758.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603450201","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603450201?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:47","pubTimestamp":1768297672,"startTime":"0","endTime":"0","summary":"证券之星消息，1月13日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格76.58元，成交9.9万股，成交金额758.14万元，买方营业部为国泰海通证券股份有限公司总部，卖方营业部为广发证券股份有限公司上海西藏南路证券营业部。近三个月该股共发生6笔大宗交易，合计成交6415.0手。该股近期无解禁股上市。截至2026年1月13日收盘，特宝生物报收于76.58元，下跌0.49%，换手率0.59%，成交量2.42万手，成交额1.86亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300030415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2602953630","title":"每周股票复盘：特宝生物（688278）发生大宗交易成交1799.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602953630","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602953630?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:48","pubTimestamp":1768074489,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，特宝生物（688278）报收于80.59元，较上周的83.68元下跌3.69%。本周，特宝生物1月5日盘中最高价报85.16元。1月9日盘中最低价报80.08元。特宝生物当前最新总市值328.96亿元，在生物制品板块市值排名10/51，在两市A股市值排名629/5182。本周关注点交易信息汇总：1月8日特宝生物发生1笔大宗交易，成交金额1799.8万元交易信息汇总1月8日特宝生物发生1笔大宗交易，成交金额1799.8万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2601575023","title":"1月8日特宝生物发生1笔大宗交易 成交金额1799.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601575023","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601575023?lang=zh_cn&edition=full","pubTime":"2026-01-08 17:34","pubTimestamp":1767864873,"startTime":"0","endTime":"0","summary":"证券之星消息，1月8日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格82.07元，成交21.93万股，成交金额1799.8万元，买方营业部为中国国际金融股份有限公司北京建国门外大街证券营业部，卖方营业部为广发证券股份有限公司厦门湖滨南路证券营业部。近三个月该股共发生6笔大宗交易，合计成交5890.0手。截至2026年1月8日收盘，特宝生物报收于82.07元，下跌2.65%，换手率0.89%，成交量3.63万手，成交额2.97亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800028044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2600391360","title":"每周股票复盘：特宝生物（688278）募集资金专户已全部注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2600391360","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600391360?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:17","pubTimestamp":1767298629,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，特宝生物报收于82.61元，较上周的85.0元下跌2.81%。本周，特宝生物12月22日盘中最高价报85.5元。本周关注点公司公告汇总：募集资金专户已全部注销，结余资金0.75万元转为永久补充流动资金。公司公告汇总特宝生物：关于募集资金专户完成销户的公告厦门特宝生物工程股份有限公司首次公开发行股票募集资金净额33,044.63万元，募投项目已全部结项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2595273634","title":"特宝生物（688278）披露关于募集资金专户完成销户的公告，12月29日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595273634","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595273634?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:34","pubTimestamp":1767018859,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，特宝生物报收于82.98元，较前一交易日上涨0.45%，最新总市值为338.72亿元。该股当日开盘82.35元，最高83.07元，最低81.4元，成交额达1.05亿元，换手率为0.31%。公司近日发布公告称，厦门特宝生物工程股份有限公司首次公开发行股票募集资金净额33,044.63万元，募投项目已全部结项。公司近日完成全部募集资金专户的注销手续，专户结余资金0.75万元已转入自有资金账户用于永久补充流动资金，相关三方监管协议相应终止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900038083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2593485200","title":"特宝生物（688278）披露首次公开发行股票募投项目结项公告，12月22日股价下跌0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593485200","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593485200?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:55","pubTimestamp":1766397349,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，特宝生物报收于84.44元，较前一交易日下跌0.66%，最新总市值为344.68亿元。该股当日开盘85.3元，最高85.5元，最低84.04元，成交额达9734.82万元，换手率为0.28%。公司近日发布公告称，厦门特宝生物工程股份有限公司首次公开发行股票募投项目“蛋白质药物生产改扩建和研发中心建设项目”“慢性乙型肝炎临床治愈研究项目”和“新药研发项目”已完成投入或达到预定可使用状态，公司决定将上述项目全部结项，并拟注销相关募集资金专户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200022944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772490273454,"stockEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":-0.0292},{"period":"3month","weight":-0.0817},{"period":"6month","weight":-0.1329},{"period":"1year","weight":-0.1037},{"period":"ytd","weight":-0.1184}],"compareEarnings":[{"period":"1week","weight":0.0246},{"period":"1month","weight":0.0157},{"period":"3month","weight":0.0731},{"period":"6month","weight":0.0968},{"period":"1year","weight":0.2595},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"厦门特宝生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8608人(较上一季度增加2.00%)","perCapita":"47419股","listingDate":"2020-01-17","address":"福建省厦门市海沧区新阳工业区翁角路330号","registeredCapital":"40818万元","survey":" 厦门特宝生物工程股份有限公司的主营业务是重组蛋白质及其长效修饰药物研发、生产和销售。公司的主要产品是派格宾、益佩生、珮金、特尔立、特尔津、特尔康、愈适达。公司产品荣膺国家重大新药创制科技重大专项成果，成功入选“2023年度中国医药生物技术十大进展”，获评“2024年度药物创新成就奖”。","listedPrice":8.24},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特宝生物,688278,特宝生物股票,特宝生物股票老虎,特宝生物股票老虎国际,特宝生物行情,特宝生物股票行情,特宝生物股价,特宝生物股市,特宝生物股票价格,特宝生物股票交易,特宝生物股票购买,特宝生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}